title: Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients.
abstract: OBJECTIVE
  To assess the prevalence and patterns of cardiac abnormalities as detected by cardiac magnetic resonance imaging (MRI) in systemic sclerosis (SSc).
  
  
  METHODS
  Fifty-two consecutive patients with SSc underwent cardiac MRI to determine morphological, functional, perfusion at rest and delayed enhancement abnormalities.
  
  
  RESULTS
  At least one abnormality on cardiac MRI was observed in 39/52 patients (75%). Increased myocardial signal intensity in T2 was observed in 6 patients (12%), thinning of left ventricle (LV) myocardium in 15 patients (29%) and pericardial effusion in 10 patients (19%). LV and right ventricle (RV) ejection fractions were altered in 12 patients (23%) and 11 patients (21%), respectively. LV diastolic dysfunction was found in 15/43 patients (35%). LV kinetic abnormalities were found in 16/52 patients (31%) and myocardial delayed contrast enhancement was detected in 11/52 patients (21%). No perfusion defects at rest were found. Patients with limited SSc had similar MRI abnormalities to patients with diffuse SSc. Seven of 40 patients (17%) without pulmonary arterial hypertension had RV dilatation.
  
  
  CONCLUSIONS
  This study shows that MRI is a reliable and sensitive technique for diagnosing heart involvement in SSc and for analysing its mechanisms, including its inflammatory, microvascular and fibrotic components. Compared with echocardiography, MRI appears to provide additional information by visualising myocardial fibrosis and inflammation. RV dilatation appeared to be non-specific for pulmonary arterial hypertension but could also reflect myocardial involvement related to SSc. Further studies are needed to determine whether cardiac MRI abnormalities have an impact on the prognosis and treatment strategy.
authors.affiliation: Department of Cardiovascular Radiology, Regional University Hospital, Lille 2 University, Lille, France.
authors.forename: A-L
authors.initials: AL
authors.lastname: Hachulla
authors.forename: D
authors.initials: D
authors.lastname: Launay
authors.forename: V
authors.initials: V
authors.lastname: Gaxotte
authors.forename: P
authors.initials: P
authors.lastname: de Groote
authors.forename: N
authors.initials: N
authors.lastname: Lamblin
authors.forename: P
authors.initials: P
authors.lastname: Devos
authors.forename: P-Y
authors.initials: PY
authors.lastname: Hatron
authors.forename: J-P
authors.initials: JP
authors.lastname: Beregi
authors.forename: E
authors.initials: E
authors.lastname: Hachulla
mesh_terms: D000328:Adult; D000368:Aged; D003287:Contrast Media; D003430:Cross-Sectional Studies; D005260:Female; D006331:Heart Diseases / Q000175:diagnosis* / Q000473:pathology; D006352:Heart Ventricles / Q000473:pathology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D045743:Scleroderma, Diffuse / Q000175:diagnosis / Q000473:pathology; D045745:Scleroderma, Limited / Q000175:diagnosis / Q000473:pathology; D012595:Scleroderma, Systemic / Q000150:complications / Q000175:diagnosis* / Q000473:pathology; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis; D018497:Ventricular Dysfunction, Right / Q000175:diagnosis
chemical_list: D003287:Contrast Media